Beginning of the month Berkshire-Hathaway exceeded the market capitalization of $1 trillion, becoming the primary ...

Eli Lilly launched a brand new type of its weight-loss drug Zepbound on Tuesday for ...

Eli Lilly's A very fashionable weight reduction drug reduced the chance of developing type 2 ...

Novo Nordisk And Eli Lilly currently dominate the booming marketplace for a category of medicine ...

Investors need to know if Eli Lilly will face the identical pricing pressure on its ...

Eli Lilly reported on Thursday Second quarter results and revenue exceeded all expectations, raising full-year ...

All cans of Eli Lilly's The hugely popular weight reduction injection Zepbound and the diabetes ...

Eli LillyThe weight reduction drug Zepbound showed advantages in patients with common kind of heart ...

The lucrative weight-loss drug market won't remain a duopoly eternally. With billions at stake, that ...

Good morning! Eli Lilly, Novo Nordisk and other pharmaceutical corporations presented encouraging data on weight-loss ...